肌少-骨质疏松症专家共识  

Sarcopenia-osteoporosis expert consensus

作　　者：黄宏兴 史晓林 李盛华[3] 马勇 孔西建 李跃华[6] 程群[7] 郭晓东[8] 刘康 万雷 中国健康促进基金会肌少-骨质疏松症专家共识委员会 HUANG Hongxing;SHI Xiaolin;LI Shenghua;MA Yong;KONG Xijian;LI Yuehua;CHENG Qun;GUO Xiaodong;LIU Kang;WAN Lei;Expert Consensus Committee on Diagnosis and Treatment of Osteoporosis in Grassroots Medical Institutions of China Health Promotion Foundation(The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangzhou 510378;The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Hangzhou 310005;Gansu Traditional Chinese Medicine Hospital,Lanzhou 730050;Affiliated Hospital of Nanjing University of Traditional Chinese Medicine,Nanjing 210004;Luoyang Orthopedic-Traumatological Hospital of Henan Province(Henan Provincial Orthopedic Hospital),Luoyang 471002;Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine,Beijing 100091;East China Hospital Affiliated to Fudan University,Shanghai 200040;Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan 430022,China;不详)

机构地区：[1]广州中医药大学第三附属医院,广东广州510378 [2]浙江中医药大学附属第二医院,浙江杭州310005 [3]甘肃省中医院,甘肃兰州730050 [4]南京中医药大学附属医院,江苏南京210004 [5]河南省洛阳正骨医院(河南省骨科医院),河南洛阳471002 [6]中国中医科学院西苑医院,北京100091 [7]复旦大学附属华东医院,上海200040 [8]华中科技大学同济医学院附属协和医院,湖北武汉430022 [9]不详

出　　处：《中国骨质疏松杂志》2022年第11期1561-1570,共10页Chinese Journal of Osteoporosis

摘　　要：肌少-骨质疏松症已成为全球性的公共健康问题和前沿研究难题。目前仍存在对肌少-骨质疏松症的临床知晓率低、重视不够、诊断治疗方法单一、管理不完善等实际问题。中国健康促进基金会组织专家编写《肌少-骨质疏松症专家共识》,为肌少-骨质疏松症的临床诊疗和科学研究提供参考。共识论述了肌少-骨质疏松症是肌少症和骨质疏松症并存的退行性代谢综合征,有共同的发病基础,诊断标准应是骨质疏松症与肌少症并存,预防比治疗更重要。肌少-骨质疏松症的治疗目标是改善肌量、肌力、身体平衡、骨量和骨质量,避免出现跌倒和骨折。肌少-骨质疏松症的管理应肌骨并重,综合诊断、规范治疗,医患合作,建立科学评估、定期随访机制。Sarcopenia-osteoporosis has become a global public health problem and frontier research problem. At present, there are still some practical problems such as single diagnosis and treatment, and imperfect management of sarcopenia-osteoporosis. The China Health Promotion Foundation organized experts to compile the Expert Consensus on sarcopenia-osteoporosis to provide reference for the clinical diagnosis, treatment and scientific research of sarcopenia-osteoporosis. The consensus discussed: sarcopenia-osteoporosis is a degenerative metabolic syndrome coexisting with sarcopenia and osteoporosis, has a common basis of pathogenesis, the diagnostic criteria should be osteoporosis and sarcopenia coexisting, prevention is more important than treatment. The goal of treatment for sarcopenia-osteoporosis is to improve muscle mass, muscle strength, body balance, bone mass, and bone quality, and to avoid falls and fractures. The management of sarcopenia-osteoporosis should pay equal attention to muscle and bone, based on comprehensive diagnosis, standardized treatment, doctor-patient cooperation, scientific evaluation and regular follow-up mechanism.

关 键 词：肌少-骨质疏松症 诊断 治疗 专家共识 

分 类 号：R589.5[医药卫生—内分泌]